Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2007-7-26
pubmed:abstractText
A recent high-density linkage screen confirmed that the HLA complex contains the strongest genetic factor for the risk of multiple sclerosis (MS). In parallel, a linkage disequilibrium analysis using 650 single nucleotide polymorphisms (SNP) markers of the HLA complex mapped the entire genetic effect to the HLA-DR-DQ subregion, reflected by the well-established risk haplotype HLA-DRB1*15,DQB1*06. Contrary to this, in a cohort of 1,084 MS patients and 1,347 controls, we show that the HLA-A gene confers an HLA-DRB1 independent influence on the risk of MS (P = 8.4x10(-10)). This supports the opposing view, that genes in the HLA class I region indeed exert an additional influence on the risk of MS, and confirms that the class I allele HLA-A*02 is negatively associated with the risk of MS (OR = 0.63, P = 7x10(-12)) not explained by linkage disequilibrium with class II. The combination of HLA-A and HLA-DRB1 alleles, as represented by HLA-A*02 and HLA-DRB1*15, was found to influence the risk of MS 23-fold. These findings imply complex autoimmune mechanisms involving both the regulatory and the effector arms of the immune system in the triggering of MS.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-10746785, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-11456302, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-11719900, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-12557126, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-1357775, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-14575912, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-14989713, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-15195659, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-15573121, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-15930013, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-15975943, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-16080120, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-16186814, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-1637966, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-16905561, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-4128558, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-4514355, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-5077731, http://linkedlifedata.com/resource/pubmed/commentcorrection/17653284-8017880
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1932-6203
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e664
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.
pubmed:affiliation
Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. boel.brynedal@ki.se
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't